Acute effect of nitric oxide on Raynaud's phenomenon in scleroderma.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 10475187.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Intra-arterial infusions of L-arginine and sodium nitroprusside significantly decreased the occurrence of laboratory-induced Raynaud's phenomenon in scleroderma patients. Raising the concentration of nitric oxide may be of therapeutic value in this population.
Medical subject headings
- Arginine
- Nitric Oxide
- Nitroprusside
- Raynaud Disease
- Scleroderma, Systemic